These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

200 related articles for article (PubMed ID: 19519386)

  • 21. Anticonvulsive effect of a selective mGluR8 agonist (S)-3,4-dicarboxyphenylglycine (S-3,4-DCPG) in the mouse pilocarpine model of status epilepticus.
    Jiang FL; Tang YC; Chia SC; Jay TM; Tang FR
    Epilepsia; 2007 Apr; 48(4):783-92. PubMed ID: 17430409
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Age-dependent anticonvulsant action of antagonists of group I glutamate metabotropic receptors in rats.
    Mares P
    Epilepsy Res; 2009 Feb; 83(2-3):215-23. PubMed ID: 19097860
    [TBL] [Abstract][Full Text] [Related]  

  • 23. In vivo modulation of extracellular hippocampal glutamate and GABA levels and limbic seizures by group I and II metabotropic glutamate receptor ligands.
    Smolders I; Lindekens H; Clinckers R; Meurs A; O'Neill MJ; Lodge D; Ebinger G; Michotte Y
    J Neurochem; 2004 Mar; 88(5):1068-77. PubMed ID: 15009663
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Depression of neuronal excitability and epileptic activities by group II metabotropic glutamate receptors in the medial entorhinal cortex.
    Zhang H; Cilz NI; Yang C; Hu B; Dong H; Lei S
    Hippocampus; 2015 Nov; 25(11):1299-313. PubMed ID: 25740117
    [TBL] [Abstract][Full Text] [Related]  

  • 25. New pharmacotherapy for epilepsy.
    Pitkanen A
    IDrugs; 2004 May; 7(5):471-7. PubMed ID: 15154109
    [TBL] [Abstract][Full Text] [Related]  

  • 26. mGlu1 and mGlu5 receptor antagonists lack anticonvulsant efficacy in rodent models of difficult-to-treat partial epilepsy.
    Löscher W; Dekundy A; Nagel J; Danysz W; Parsons CG; Potschka H
    Neuropharmacology; 2006 Jun; 50(8):1006-15. PubMed ID: 16563443
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Modulators of metabotropic glutamate receptors microinfused into perirhinal cortex: anticonvulsant effects in rats challenged with soman.
    Myhrer T; Enger S; Aas P
    Eur J Pharmacol; 2010 Jun; 636(1-3):82-7. PubMed ID: 20347777
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Drug-mediated neuroprotection and antiepileptogenesis: animal data.
    Pitkänen A
    Neurology; 2002 Nov; 59(9 Suppl 5):S27-33. PubMed ID: 12428029
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The mGlu(2/3) agonist 2R,4R-4-aminopyrrolidine-2,4-dicarboxylate, is anti- and proconvulsant in DBA/2 mice.
    Moldrich RX; Talebi A; Beart PM; Chapman AG; Meldrum BS
    Neurosci Lett; 2001 Feb; 299(1-2):125-9. PubMed ID: 11166954
    [TBL] [Abstract][Full Text] [Related]  

  • 30. New visions in the pharmacology of anticonvulsion.
    Löscher W
    Eur J Pharmacol; 1998 Jan; 342(1):1-13. PubMed ID: 9544786
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Anticonvulsant action of an antagonist of metabotropic glutamate receptors mGluR5 MPEP in immature rats.
    Lojková D; Mares P
    Neuropharmacology; 2005; 49 Suppl 1():219-29. PubMed ID: 15950993
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Excitatory aminoacids and epileptic seizures in immature brain.
    Mares P; Folbergrová J; Kubová H
    Physiol Res; 2004; 53 Suppl 1():S115-24. PubMed ID: 15119942
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Seizures induced in immature rats by homocysteic acid and the associated brain damage are prevented by group II metabotropic glutamate receptor agonist (2R,4R)-4-aminopyrrolidine-2,4-dicarboxylate.
    Folbergrová J; Druga R; Otáhal J; Haugvicová R; Mares P; Kubová H
    Exp Neurol; 2005 Apr; 192(2):420-36. PubMed ID: 15755559
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Small molecule anticonvulsant agents with potent in vitro neuroprotection.
    Brenneman DE; Smith GR; Zhang Y; Du Y; Kondaveeti SK; Zdilla MJ; Reitz AB
    J Mol Neurosci; 2012 Jun; 47(2):368-79. PubMed ID: 22535312
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The role and potential mechanism of resveratrol in the prevention and control of epilepsy.
    Lu S; Wang X
    Future Med Chem; 2015; 7(15):2005-18. PubMed ID: 26505553
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Metabotropic glutamate receptor subtypes as targets for neuroprotective drugs.
    Bruno V; Battaglia G; Copani A; D'Onofrio M; Di Iorio P; De Blasi A; Melchiorri D; Flor PJ; Nicoletti F
    J Cereb Blood Flow Metab; 2001 Sep; 21(9):1013-33. PubMed ID: 11524608
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Anti-seizure medications and estradiol for neuroprotection in epilepsy: the 2013 update.
    Velisek L; Nebieridze N; Chachua T; Veliskova J
    Recent Pat CNS Drug Discov; 2013 Apr; 8(1):24-41. PubMed ID: 23477307
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Selective mGluR5 receptor antagonist or agonist provides neuroprotection in a rat model of focal cerebral ischemia.
    Bao WL; Williams AJ; Faden AI; Tortella FC
    Brain Res; 2001 Dec; 922(2):173-9. PubMed ID: 11743947
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Nonsteroidal anti-inflammatory drugs in clinical and experimental epilepsy.
    Radu BM; Epureanu FB; Radu M; Fabene PF; Bertini G
    Epilepsy Res; 2017 Mar; 131():15-27. PubMed ID: 28212985
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Neuroprotective activity of antiepileptic drugs].
    Czuczwar K; Czuczwar M; Cieszczyk J; Gawlik P; Luszczki JJ; Borowicz KK; Czuczwar SJ
    Przegl Lek; 2004; 61(11):1268-71. PubMed ID: 15727029
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.